ISSN (print) 1726-9806     ISSN (online) 1818-474X
No. 3 (2024), ORGANIZATION AND LEGAL ISSUES
No. 3 (2024)
ORGANIZATION AND LEGAL ISSUES

Problems of early diagnosis and correction of protein-energy malnutrition in patients at high operative and anesthetic risk in abdominal oncosurgery: a narrative review

Published 31.07.2024
Ilya N. Leyderman
Almazov National Medical Research Centre, St. Petersburg, Russia
https://orcid.org/0000-0001-8519-7145
A.Yu. Medvedev
Krasnoyarsk Regional Clinical Oncologic Dispensary named after A.I. Kryzhanovsky, Krasnoyarsk, Russia
https://orcid.org/0009-0001-0112-5935
O.G. Eremeeva
Krasnoyarsk Regional Clinical Oncologic Dispensary named after A.I. Kryzhanovsky, Krasnoyarsk, Russia
https://orcid.org/0009-0009-5093-338X
R.A. Zukov
Krasnoyarsk Regional Clinical Oncologic Dispensary named after A.I. Kryzhanovsky, Krasnoyarsk, Russia; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia
https://orcid.org/0000-0002-7210-3020
2024-3
PDF_2024-3_96-113 (Russian)

Keywords

protein energy-malnutrition
nutritional status
high surgical and anesthetic risk
nutritional support
surgical oncology

How to Cite

Leyderman I.N., Medvedev A.Y., Eremeeva O.G., Zukov R.A. Problems of early diagnosis and correction of protein-energy malnutrition in patients at high operative and anesthetic risk in abdominal oncosurgery: a narrative review. Annals of Critical Care. 2024;(3):96–113. doi:10.21320/1818-474X-2024-3-96-113.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA ГОСТ

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Statistics

Annotation views: 1179
PDF_2024-3_96-113 (Russian) downloads: 531

Language

English Русский

Most reader

Social Networks

Keywords

Abstract

INTRODUCTION: The share of patients with high surgical and anesthesia risk in the total structure of oncological patients is increasing every year. Patients with protein-energy malnutrition (PEM) are characterized by a high frequency of postoperative complications. Progression of PEM in patients with high surgical and anesthesia risk occurs faster due to both the oncologic process itself and severe comorbidity. OBJECTIVE: To summarize and analyze information on modern methods of early diagnosis and correction of PEM in abdominal oncosurgery patients at high operative and anesthetic risk in the perioperative period. MATERIALS AND METHODS: A systematic search and selection of publications was performed using the bibliographic databases PubMed and eLibrary. Studies published in the last 15 years (2008–2023) were analyzed to investigate the problem. Relevant studies were limited to systematic literature reviews, meta-analyses, randomized controlled trials, prospective observational studies, retrospective studies. RESULTS: The use of special assessment systems that identify different stages of PEM (CASC IN, miniCASCO, new cachexia staging scale 2018) in cancer patients at high surgical and anesthetic risk creates conditions for the implementation of a personalized approach to the selection of nutritional support program in the perioperative period. Assessment of nutritional status, including the analysis of laboratory markers of malnutrition (total protein, albumin, serum transferrin), as well as qualitative assessment of body composition using bioimpedance analysis contribute to the early detection of PEM and allow for maximum personalization of nutritional support and hydration of this patients. CONCLUSIONS: This narrative review has shown that currently it is rather difficult to formulate algorithms for diagnostics and correction of PEM in patients with high surgical and anesthesia risk in abdominal oncosurgery. Research is required to determine the effectiveness of different scales of PEM staging. A personalized approach to early diagnosis and correction of PEM is one of the most promising strategies to reduce the incidence of postoperative complications in this category of patients.

PDF_2024-3_96-113 (Russian)

Full-text of the article is available for this locale: Russian.

References

  1. Сергиенко А.Д., Хороненко В.Э., Гамеева Е.В. и др. Влияние нутритивной терапии на показатели качества жизни больных раком желудка на этапе хирургического лечения. Исследования и практика в медицине. 2019; 6(3): 108–14. DOI: 10.17709/2409-2231-2019-6-3-10 [Sergienko A.D., Khoronenko V.E., Gameeva E.V., et al. The effect of nutritional therapy on quality of life indicators for patients with gastric cancer at the stage of surgical treatment. Research and Practical Medicine Journal (Issled. prakt. med.). 2019; 6(3): 108–14. DOI: 10.17709/2409-2231- 2019-6-3-10 (In Russ)]
  2. Гамеева Е.В., Хороненко В.Э., Шеметова М.М. Нутритивная недостаточность и терапия онкологических пациентов. Современный взгляд на проблему. Сибирский онкологический журнал. 2020; 19(2): 116–24. DOI: 10.21294/1814-4861-2020-19-2-116-124 [Gameeva E.V., Khoronenko V.E., Shemetova M.M. Nutritional insufficiency and therapy for cancer patients. Modern view on the problem. Siberian Journal of Oncology. 2020; 19(2): 116–24. DOI: 10.21294/1814-4861-2020-19-2-116-124 (In Russ)]
  3. Обухова О.А., Курмуков И.А., Абу-Хайдар О.Б. Нутритивная поддержка первичных больных раком пищевода (аналитический обзор). Современная Онкология. 2023; 25(2): 244–9. DOI: 10.26442/18151434.2023.2.202274 [Obukhova O.A., Kurmukov I.A., Abouhaidar O.B. Nutritional support for primary patients with esophageal cancer (analytical review). Journal of Modern Oncology. 2023; 25(2): 244–9. DOI: 10.26442/18151434.2023.2.202274 (In Russ)]
  4. World Health Organization. Cancer fact sheet. WHO 2017 Available online: http://www.who.int/mediacentre/factsheets/fs297/en
  5. Bray F., Ferlay J., Soerjomataram I., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 2018; 68(6): 394–424. DOI: 10.3322/caac.21492
  6. Lee J.H., Nam B.H., Ryu K.W., et al. Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer. Br J Surg. 2015; 102(12): 1500–5. DOI: 10.1002/bjs.9902
  7. McGuigan A., Kelly P., Turkington R.C., et al. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018; 24(43): 4846–61. DOI: 10.3748/wjg.v24.i43.4846
  8. Fransen L.F.C., Luyer M.D.P. Effects of improving outcomes after esophagectomy on the short- and long-term: a review of literature. J Thorac Dis. 2019; 11(Suppl 5): S845–S850. DOI: 10.21037/jtd.2018.12.09
  9. Салтанов А.И., Сельчук В.И., Снеговой А.В. Основы нутритивной поддержки в онкологической клинике: руководство для врачей. М.: МЕДпресс-информ, 2009. 240 с. [Saltanov A.I., Sel'chuk V.I., Snegovoj A.V. Osnovy nutritivnoj podderzhki v onkologicheskoj klinike: rukovodstvo dlya vrachej. M.: MEDpress-inform, 2009. 240 p. (In Russ)]
  10. Gabrielson D.K., Scaffidi D., Leung E., et al. Use of an abridged scored Patient-Generated Subjective Global Assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting. Nutr Cancer. 2013; 65(2): 234–9. DOI: 10.1080/01635581.2013.755554
  11. Malihi Z., Kandiah M., Chan Y.M., et al. Nutritional status and quality of life in patients with acute leukaemia prior to and after induction chemotherapy in three hospitals in Tehran, Iran: a prospective study. J Hum Nutr Diet. 2013; 26(Suppl 1): 123–31. DOI: 10.1111/jhn.12043
  12. Grace E.M., Shaw C., Lalji A., et al. Nutritional status, the development and persistence of malnutrition and dietary intake in oesophago-gastric cancer: a longitudinal cohort study. J Hum Nutr Diet. 2018; 31(6): 785–92. DOI: 10.1111/jhn.12588
  13. Marshall K.M., Loeliger J., Nolte L., et al. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin Nutr. 2019; 38(2): 644–51. DOI: 10.1016/j.clnu.2018.04.007
  14. La Torre M., Ziparo V., Nigri G., et al. Malnutrition and pancreatic surgery: prevalence and outcomes. J Surg Oncol. 2013; 107(7): 702–8. DOI: 10.1002/jso.23304
  15. Nitenberg G., Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol. 2000; 34(3): 137–68. DOI: 10.1016/s1040-8428(00)00048-2
  16. Arends J., Baracos V., Bertz H., et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017; 36(5): 1187–96. DOI: 10.1016/j.clnu.2017.06.017
  17. Arends J., Bachmann P., Baracos V., et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1): 11–48. DOI: 10.1016/j.clnu.2016.07.015
  18. Weimann A., Braga M., Carli F., et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017; 36(3): 623–50. DOI: 10.1016/j.clnu.2017.02.013
  19. Лейдерман И.Н., Грицан А.И., Заболотских И.Б. и др. Периоперационная нутритивная поддержка. Методические рекомендации Федерации анестезиологов и реаниматологов. Вестник интенсивной терапии им. А.И. Салтанова. 2021; 4: 7–20. DOI: 10.21320/1818-474X-2021-4-7-20 [Leyderman I.N., Gritsan A.I., Zabolotskikh I.B., et al. Perioperative nutritional support. Clinical practice recommendations of the national “Federation of Anesthesiologists and Reanimatologists”. Annals of Critical Care. 2021; 4: 7–20. DOI: 10.21320/1818-474X-2021-4-7-20 (In Russ)]
  20. Сергеев И.В., Петрова М.В., Шестопалов А.Е. и др. Нутритивный статус пациентов в длительном критическом состоянии. Общая реаниматология. 2023; 19(4): 4–11. DOI: 10.15360/1813-9779-2023-4-2329 [Sergeev I.V., Petrova M.V., Shestopalov A.E., et al. Nutritional Status of Patients with Chronic Critical Illness. General Reanimatology. 2023; 19(4): 4–11. DOI: 10.15360/1813-9779-2023-4-2329 (In Russ)]
  21. London M.J., Hur K., Schwartz G.G., et al. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery JAMA. 2013; 309(16): 1704–13. DOI: 10.1001/jama.2013.4135
  22. Ghaferi A.A., Birkmeyer J.D., Dimick J.B. Variation in hospital mortality associated with inpatient surgery. N Engl J Med. 2009; 361(14): 1368–75. DOI: 10.1056/NEJMsa0903048
  23. Заболотских И.Б., Трембач Н.В. Пациенты высокого периоперационного риска: два подхода к стратификации. Вестник интенсивной терапии им. А.И. Салтанова. 2019; 4: 34–46. DOI: 10.21320/1818-474X-2019-4-34-46 [Zabolotskikh I.B., Trembach N.V. High perioperative risk patients: two approaches to stratification. Review. Annals of Critical Care. 2019; 4: 34–46. DOI: 10.21320/1818-474X-2019-4-34-46 (In Russ)]
  24. Eichelmann A.K., Saidi M., Lindner K., et al. Impact of preoperative risk factors on outcome after gastrectomy. World J Surg Oncol. 2020; 18(1): 17. DOI: 10.1186/s12957-020-1790-6
  25. Левин Я.И., Корячкин В.А. Новая классификация оценки физического статуса пациента Американского общества анестезиологов (80 лет эволюции). Анестезиология и реаниматология. 2021; 6: 107–9. DOI: 10.17116/anaesthesiology2021061107 [Levin Ya.I., Koriachkin V.A. A new classification for assessing the physical status of a patient by the American Society of Anesthesiologists (80 years of evolution). Russian Journal of Anesthesiology and Reanimatology. 2021; 6: 107–9. DOI: 10.17116/anaesthesiology2021061107 (In Russ)]
  26. ASA Physical Status Classification System. Accessed May 25, 2021. https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system
  27. Koo C.Y., Hyder J.A., Wanderer J.P., et al. A meta-analysis of the predictive accuracy of postoperative mortality using the American Society of Anesthesiologists' physical status classification system. World J Surg. 2015; 39(1): 88–103. DOI: 10.1007/s00268-014-2783-9
  28. Заболотских И.Б., Трембач Н.В., Магомедов М.А. и др. Сравнительная оценка шкал прогнозирования неблагоприятного послеоперационного исхода: Предварительные результаты МЦИ «Роль сопутствующих заболеваний в стратификации риска послеоперационных осложнений в абдоминальной хирургии STOPRISK». Вестник интенсивной терапии им. А.И. Салтанова. 2022; 3: 27–44. DOI: 10.21320/1818-474X-2022-3-27-44 [Zabolotskikh I.B., Trembach N.V., Magomedov M.A., et al. Comparative evaluation of scales for predicting an unfavorable postoperative outcome: Preliminary results of the multicenter study “The role of concomitant diseases in the stratification of the risk of postoperative complications in abdominal surgery STOPRISK”. Annals of Critical Care. 2022; 3: 27–44. DOI: 10.21320/1818-474X-2022-3-27-44 (In Russ)]
  29. Brooks M.J., Sutton R., Sarin S. Comparison of Surgical Risk Score, POSSUM and p-POSSUM in higher-risk surgical patients. Br J Surg. 2005; 92(10): 1288–92. DOI: 10.1002/bjs.5058
  30. Mukherjee S., Kedia A., Goswami J., et al. Validity of P-POSSUM in adult cancer surgery (PACS). J Anaesthesiol Clin Pharmacol. 2022; 38(1): 61–5. DOI: 10.4103/joacp.JOACP_128_20
  31. Wanjiang F., Xiaobo Z., Xin W., et al. Application of POSSUM and P-POSSUM scores in the risk assessment of elderly hip fracture surgery: systematic review and meta-analysis. J Orthop Surg Res. 2022; 17(1): 255. DOI: 10.1186/s13018-022-03134-0
  32. Hu Z.W., Xin R.Q., Xia Y.J., et al. Application of POSSUM and P-POSSUM in Surgical Risk Assessment of Elderly Patients Undergoing Hepatobiliary and Pancreatic Surgery. Clin Interv Aging. 2020; 15: 1121–8. DOI: 10.2147/CIA.S258659
  33. Dutton J., Zardab M., De Braal V.J.F., et al. The accuracy of pre-operative (P)-POSSUM scoring and cardiopulmonary exercise testing in predicting morbidity and mortality after pancreatic and liver surgery: A systematic review. Ann Med Surg (Lond). 2020; 62: 1–9. DOI: 10.1016/j.amsu.2020.12.016
  34. Ngulube A., Muguti G.I., Muguti E.G. Validation of POSSUM, P-POSSUM and the surgical risk scale in major general surgical operations in Harare: A prospective observational study. Ann Med Surg (Lond). 2019; 41: 33–9. DOI: 10.1016/j.amsu.2019.03.007
  35. Karan N., Siddiqui S., Sharma K.S., et al. Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth-POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries. Head Neck. 2020; 42(10): 2968–74. DOI: 10.1002/hed.26354
  36. Chang C.M., Yin W.Y., Wei C.K., et al. Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery PLoS One. 2016; 11(2): e0148076. DOI: 10.1371/journal.pone.0148076
  37. Fowler H., Belot A., Ellis L., et al. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers. BMC Cancer. 2020; 20(1): 2. DOI: 10.1186/s12885-019-6472-9
  38. Lobo D.N., Gianotti L., Adiamah A., et al. Perioperative nutrition: Recommendations from the ESPEN expert group. Clin Nutr. 2020; 39(11): 3211–27. DOI: 10.1016/j.clnu.2020.03.038
  39. Charlton K., Nichols C., Bowden S., et al. Poor nutritional status of older subacute patients predicts clinical outcomes and mortality at 18 months of follow-up. Eur J Clin Nutr. 2012; 66(11): 1224–8. DOI: 10.1038/ejcn.2012.130
  40. Зитта Д.В., Терехина Н.А., Субботин В.М. Клинико-биохимическая оценка эффективности программы оптимизации периоперационного ведения больных в плановой колоректальной хирургии. Колопроктология. 2015; 2(52): 18–29. [Zitta D., Terekchina N., Subbotin V. Clinical and biochemical evaluation of the effectiveness of fast track protocol in elective colorectal surgery Koloproktologiya. 2015; 2(52): 18–29. (In Russ)]
  41. Fearon K., Strasser F., Anker S.D., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5): 489–95. DOI: 10.1016/S1470-2045(10)70218-7
  42. Silva T.H., Schilithz A.O.C., Peres W.A.F., et al. Neutrophil-lymphocyte ratio and nutritional status are clinically useful in predicting prognosis in colorectal cancer patients. Nutr Cancer. 2020; 72(8): 1345–54. DOI: 10.1080/01635581.2019.1679198
  43. Sun Z., Kong X.J., Jing X., et al. Nutritional Risk Screening 2002 as a Predictor of Postoperative Outcomes in Patients Undergoing Abdominal Surgery: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. PLoS One. 2015; 10(7): e0132857. DOI: 10.1371/journal.pone.0132857
  44. Dou L., Wang X., Cao Y., et al. Relationship between Postoperative Recovery and Nutrition Risk Screened by NRS 2002 and Nutrition Support Status in Patients with Gastrointestinal Cancer. Nutr Cancer. 2020; 72(1): 33–40. DOI: 10.1080/01635581.2019.1612927
  45. Loan B.T.H., Nakahara S., Tho B.A., et al. Nutritional status and postoperative outcomes in patients with gastrointestinal cancer in Vietnam: a retrospective cohort study. Nutrition. 2018; 48: 117–21. DOI: 10.1016/j.nut.2017.11.027
  46. Сытов А.В., Зузов С.А., Кукош М.Ю. и др. Практические рекомендации по лечению синдрома анорексии-кахексии у онкологических больных. Злокачественные опухоли: Практические рекомендации RUSSCO #3s2. 2022; 12: 134–9. DOI: 10.18027/2224-5057-2022-12-3s2-134-139 [Sytov A.V., Zuzov S.A., Kukosh M.Yu., et al. Prakticheskie rekomendatsii po lecheniiu sindroma anoreksii-kakheksii u onkologicheskikh bolnykh Malignant tumours Russian Society of Clinical Oncology Prakticheskie rekomendatsii RUSSCO 3s2. 2022; 12: 134–9. DOI: 10.18027/2224-5057-2022-12-3s2-134-139 (In Russ)]
  47. Zhang Q., Yu S., Li Q., et al. Preoperative Nutritional Status in Elderly Inpatients with Gastrointestinal Cancer and Its Linear Association with Frailty. Nutr Cancer. 2022; 74(4): 1376–87. DOI: 10.1080/01635581.2021.1955284
  48. Jensen G.L. Global Leadership Conversation: Addressing Malnutrition. JPEN J Parenter Enteral Nutr. 2016; 40(4): 455–7. DOI: 10.1177/0148607116640274
  49. Cederholm T., Jensen G.L. To create a consensus on malnutrition diagnostic criteria: A report from the Global Leadership Initiative on Malnutrition (GLIM) meeting at the ESPEN Congress 2016. Clin Nutr. 2017; 36(1): 7–10. DOI: 10.1016/j.clnu.2016.12.001
  50. Cederholm T., Jensen G.L., Correia M.I.T.D., et al. GLIM criteria for the diagnosis of malnutrition — A consensus report from the global clinical nutrition community. Clin Nutr. 2019; 38(1): 1–9. DOI: 10.1016/j.clnu.2018.08.002
  51. Afşar B., Sezer S., Ozdemir F.N., et al. Malnutrition-inflammation score is a useful tool in peritoneal dialysis patients. Perit Dial Int. 2006; 26(6): 705–11.
  52. Fouladiun M., Körner U., Bosaeus I., et al. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer. 2005; 103(10): 2189–98. DOI: 10.1002/cncr.21013
  53. Kayacan O., Karnak D., Beder S., et al. Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol. 2006; 29(4): 328–35. DOI: 10.1097/01.coc.0000221300.72657.e0
  54. Walsh D., Mahmoud F., Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer. 2003; 11(1): 60–2. DOI: 10.1007/s00520-002-0390-z
  55. Nagata S., Maeda S., Nagamatsu S., et al. Prognostic Nutritional Index Considering Resection Range Is Useful for Predicting Postoperative Morbidity of Hepatectomy. J Gastrointest Surg. 2021; 25(11): 2788–95. DOI: 10.1007/s11605-020-04893-z
  56. Evans D.C., Corkins M.R., Malone A., et al. The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper Nutr Clin Pract. 2021; 36(1): 22–8. DOI: 10.1002/ncp.10588
  57. Eckart A., Struja T., Kutz A., et al. Relationship of Nutritional Status, Inflammation, and Serum Albumin Levels During Acute Illness: A Prospective Study. Am J Med. 2020; 133(6): 713–22.e7. DOI: 10.1016/j.amjmed.2019.10.031
  58. McMillan D.C. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009; 12(3): 223–6. DOI: 10.1097/MCO.0b013e32832a7902
  59. Brenner D.R., Scherer D., Muir K., et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev. 2014; 23(9): 1729–51. DOI: 10.1158/1055-9965.EPI-14-0064
  60. Zhang Z., Ni H. C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesth Intensive Care. 2011; 39(5): 854–61. DOI: 10.1177/0310057X1103900509
  61. Cha K., Choi S.P., Kim S.H., et al. Prognostic value of ambulation ability with albumin and C-reactive protein to predict 28-day mortality in elderly sepsis patients: a retrospective multicentre registry-based study. BMC Geriatr. 2022; 22(1): 661. DOI: 10.1186/s12877-022-03339-2
  62. Miyatani K., Sawata S., Makinoya M., et al. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer. BMC Cancer. 2022; 22(1): 641. DOI: 10.1186/s12885-022-09716-9
  63. Scott H.R., McMillan D.C., Forrest L.M., et al. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer. 2002; 87(3): 264–7. DOI: 10.1038/sj.bjc.6600466
  64. Slaviero K.A., Read J.A., Clarke S.J., et al. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer. 2003; 46(2): 148–57. DOI: 10.1207/S15327914NC4602_07
  65. Jiang Y., Yang Z., Wu Q., et al. The association between albumin and C-reactive protein in older adults. Medicine (Baltimore). 2023; 102(34): e34726. DOI: 10.1097/MD.0000000000034726
  66. Maruyama S., Okamura A., Kanie Y., et al. C-reactive protein to prealbumin ratio: a useful inflammatory and nutritional index for predicting prognosis after curative resection in esophageal squamous cell carcinoma patients. Langenbecks Arch Surg. 2022; 407(5): 1901–9. DOI: 10.1007/s00423-022-02508-6
  67. Сивков А.О., Лейдерман И.Н., Сивков О.Г. и др. Оценка и прогностическая значимость показателей нутритивного статуса у травматологических и хирургических пациентов отделений реанимации и интенсивной терапии: систематический обзор литературы. Политравма, 2021; 3: 91–102. DOI: 10.24412/1819-1495-2021-3-91-102 [Sivkov A.O., Leyderman I.N., Sivkov O.G., et al. Estimation and predictive significance of nutritional status values in trauma and surgical patients of intensive care unit: a systematic literature review. Polytrauma, 2021; 3: 91–102. DOI: 10.24412/1819-1495-2021-3-91-102 (In Russ)]
  68. Karakaş S., Demirayak G., Önder A.B., et al. The Association between the Preoperative Prognostic Nutritional Index and the Controlling Nutritional Status Score on Tumor Stage, Chemotherapeutic Response and Overall Survival in Ovarian Cancer. Nutr Cancer. 2022; 74(5): 1770–9. DOI: 10.1080/01635581.2021.2022170
  69. Alam I., Alam W., Aljuraiban G.S., et al. Nutritional, immunological and antioxidant defense status of outpatients diagnosed with colorectal cancer — a case-control study of the little-studied population. Nutr Cancer. 2020; 72(8): 1307–20. DOI: 10.1080/01635581.2019.1673448
  70. Yu Y.L., Tseng W.K., Fan C.W., et al. Pretreatment Nutrition-Inflammation Biomarkers Correlated with Differential Cytokine Profiles in Taiwanese Patients with Colorectal Cancer. Nutr Cancer. 2022; 74(5): 1614–24. DOI: 10.1080/01635581.2021.1957130
  71. Луфт В.М., Афончиков В.С., Дмитриев А.В. и др. Руководство по клиническому питанию. Под ред. проф. В.М. Луфта. 3-е переизд. СПб.: Арт-Экспресс, 2016. 492 с. [Luft V.M., Afonchikov V.S., Dmitriev A.V., et al. Guide to clinical food. Ed. by prof. V.M. Luft. 3rd izd. St. Petersburg: Art Express, 2016. 492 p. (In Russ)]
  72. Quigley D.A., Kristensen V. Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells. Mol Oncol. 2015; 9(10): 2054–62. DOI: 10.1016/j.molonc.2015.10.003
  73. Harvie M.N., Campbell I.T., Thatcher N., et al. Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy. J Hum Nutr Diet. 2003; 16(5): 323–6. DOI: 10.1046/j.1365-277x.2003.00459.x
  74. Cardoso I.C.R., Aredes M.A., Chaves G.V. Applicability of the direct parameters of bioelectrical impedance in assessing nutritional status and surgical complications of women with gynecological cancer. Eur J Clin Nutr. 2017; 71(11): 1278–84. DOI: 10.1038/ejcn.2017.115
  75. Prado C.M., Birdsell L.A., Baracos V.E. The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care. 2009; 3(4): 269–75. DOI: 10.1097/SPC.0b013e328331124a
  76. Chambard L., Girard N., Ollier E., et al. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers. Bone. 2018; 108: 202–9. DOI: 10.1016/j.bone.2018.01.004
  77. Ryan A.M., Power D.G., Daly L., et al. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later. Proc Nutr Soc. 2016; 75(2): 199–211. DOI: 10.1017/S002966511500419X
  78. Baldwin C.E., Fetterplace K., Beach L., et al. Early Detection of Muscle Weakness and Functional Limitations in the Critically Ill: A Retrospective Evaluation of Bioimpedance Spectroscopy. JPEN J Parenter Enteral Nutr. 2020; 44(5): 837–48. DOI: 10.1002/jpen.1719
  79. Artero A., Sáez Ramírez T., Muresan B.T., et al. The Effect of Fasting on Body Composition Assessment in Hospitalized Cancer Patients. Nutr Cancer. 2023; 75(8): 1610–8. DOI: 10.1080/01635581.2023.2218039
  80. Morshed K., Mlak R., Smoleń A. Application of bioelectrical impedance analysis in monitoring patients with head and neck cancer after surgical intervention. Otolaryngol Pol. 2022; 77(2): 1–5. DOI: 10.5604/01.3001.0016.1853
  81. Almada-Correia I., Neves P.M., Mäkitie A., et al. Body Composition Evaluation in Head and Neck Cancer Patients: A Review. Front Oncol. 2019; 9: 1112. DOI: 10.3389/fonc.2019.01112
  82. Cotogni P., Caccialanza R., Pedrazzoli P., et al. Monitoring Response to Home Parenteral Nutrition in Adult Cancer Patients. Healthcare (Basel). 2020; 8(2): 183. DOI: 10.3390/healthcare8020183
  83. Earthman C.P. Body Composition Tools for Assessment of Adult Malnutrition at the Bedside: A Tutorial on Research Considerations and Clinical Applications. JPEN J Parenter Enteral Nutr. 2015; 39(7): 787–822. DOI: 10.1177/0148607115595227
  84. Sheean P., Gonzalez M.C., Prado C.M., et al. American Society for Parenteral and Enteral Nutrition Clinical Guidelines: The Validity of Body Composition Assessment in Clinical Populations. JPEN J Parenter Enteral Nutr. 2020; 44(1): 12–43. DOI: 10.1002/jpen.1669
  85. Marra M., Sammarco R., De Lorenzo A., et al. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media Mol Imaging. 2019; 2019: 3548284. DOI: 10.1155/2019/3548284
  86. Hui D., Bansal S., Morgado M., et al. Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer. 2014; 120(14): 2207–14. DOI: 10.1002/cncr.28624
  87. Kilic M.K., Kizilarslanoglu M.C., Arik G., et al. Association of Bioelectrical Impedance Analysis-Derived Phase Angle and Sarcopenia in Older Adults. Nutr Clin Pract. 2017; 32(1): 103–9. DOI: 10.1177/0884533616664503
  88. Uemura K., Yamada M., Okamoto H. Association of bioimpedance phase angle and prospective falls in older adults. Geriatr Gerontol Int. 2019; 19(6): 503–7. DOI: 10.1111/ggi.13651
  89. Uemura K., Doi T., Tsutsumimoto K., et al. Predictivity of bioimpedance phase angle for incident disability in older adults. J Cachexia Sarcopenia Muscle. 2020; 11(1): 46–54. DOI: 10.1002/jcsm.12492
  90. Lukaski H.C., Kyle U.G., Kondrup J. Assessment of adult malnutrition and prognosis with bioelectrical impedance analysis: phase angle and impedance ratio. Curr Opin Clin Nutr Metab Care. 2017; 20(5): 330–9. DOI: 10.1097/MCO.0000000000000387
  91. Norman K., Stobäus N., Zocher D., et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010; 92(3): 612–9. DOI: 10.3945/ajcn.2010.29215
  92. Bering T., Diniz K.G.D., Coelho M.P.P., et al. Bioelectrical Impedance Analysis-Derived Measurements in Chronic Hepatitis C: Clinical Relevance of Fat-Free Mass and Phase Angle Evaluation. Nutr Clin Pract. 2018; 33(2): 238–46. DOI: 10.1177/0884533617728487
  93. de Blasio F., Di Gregorio A., de Blasio F., et al. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respir Med. 2018; 134: 1–5. DOI: 10.1016/j.rmed.2017.11.006
  94. Pena N.F., Mauricio S.F., Rodrigues A.M.S., et al. Association Between Standardized Phase Angle, Nutrition Status, and Clinical Outcomes in Surgical Cancer Patients. Nutr Clin Pract. 2019; 34(3): 381–6. DOI: 10.1002/ncp.10110
  95. Norman K., Wirth R., Neubauer M., et al. The bioimpedance phase angle predicts low muscle strength, impaired quality of life, and increased mortality in old patients with cancer. J Am Med Dir Assoc. 2015; 16(2): 173.e17–173.e1.73E22. DOI: 10.1016/j.jamda.2014.10.024
  96. de Blasio F., Santaniello M.G., de Blasio F., et al. Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease. Eur J Clin Nutr. 2017; 71(11): 1336–40. DOI: 10.1038/ejcn.2017.147
  97. Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Sarcopenia: revised European consensus on definition and diagnosis Age Ageing. 2019; 48(1): 16–31. DOI: 10.1093/ageing/afy169
  98. Mueller T.C., Reik L., Prokopchuk O., et al. Measurement of body mass by bioelectrical impedance analysis and computed tomography in cancer patients with malnutrition — a cross-sectional observational study. Medicine (Baltimore). 2020; 99(50): e23642. DOI: 10.1097/MD.0000000000023642
  99. Nwosu A.C., Mayland C.R., Mason S., et al. Bioelectrical impedance vector analysis (BIVA) as a method to compare body composition differences according to cancer stage and type. Clin Nutr ESPEN. 2019; 30: 59–66. DOI: 10.1016/j.clnesp.2019.02.006
  100. Haverkort E.B., Reijven P.L., Binnekade J.M., et al. Bioelectrical impedance analysis to estimate body composition in surgical and oncological patients: a systematic review. Eur J Clin Nutr. 2015; 69(1): 3–13. DOI: 10.1038/ejcn.2014.203
  101. Argilés J.M., López-Soriano F.J., Toledo M., et al. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle. 2011; 2(2): 87–93. DOI: 10.1007/s13539-011-0027-5
  102. Argilés J.M., Betancourt A., Guàrdia-Olmos J., et al. Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool. Front Physiol. 2017; 8: 92. DOI: 10.3389/fphys.2017.00092
  103. Miller J., Wells L., Nwulu U., et al. Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review. Am J Clin Nutr. 2018; 108(6): 1196–208. DOI: 10.1093/ajcn/nqy244
  104. Argilés J.M., López- Soriano F.J., Castillejo M., et al. CASC-IN: A New Tool to Diagnose Pre-Cachexia in Cancer Patients. Ann Clin Oncol. 2019; 2(4): 4–5. DOI: 10.31487/j.ACO.2019.04.03
  105. Penafuerte C.A., Gagnon B., Sirois J., et al. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer. 2016; 114(6): 680–7. DOI: 10.1038/bjc.2016.3
  106. Argilés J.M., López-Soriano F.J., Stemmler B., Busquets S. Novel targeted therapies for cancer cachexia. Biochem J. 2017; 474(16): 2663–78. DOI: 10.1042/BCJ20170032
  107. Zhou T., Wang B., Liu H., et al. Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients. J Cachexia Sarcopenia Muscle. 2018; 9(2): 306–14. DOI: 10.1002/jcsm.12275
  108. Low D.E., Allum W., De Manzoni G., et al. Guidelines for Perioperative Care in Esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations. World J Surg. 2019; 43(2): 299–330. DOI: 10.1007/s00268-018-4786-4
  109. Gianotti L., Besselink M.G., Sandini M., et al. Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2018; 164(5): 1035–48. DOI: 10.1016/j.surg.2018.05.040
  110. Lu Y., Carey S. Translating Evidence-Based Practice Guidelines into a Summary of Recommendations for the Nutrition Management of Upper Gastrointestinal Cancers. Nutr Clin Pract. 2014; 29(4): 518–25. DOI: 10.1177/0884533614532501
  111. Lahoud J., Bazzi K., Yeo D., et al. Survey of nutritional practices in total gastrectomy and oesophagectomy procedures. Nutr Diet. 2019; 76(2): 135–40. DOI: 10.1111/1747-0080.12447
  112. Burden S., Todd C., Hill J., et al. Pre-operative nutrition support in patients undergoing gastrointestinal surgery. Cochrane Database Syst Rev. 2012; 11: CD008879. DOI: 10.1002/14651858.CD008879.pub2
  113. Heyland D.K., Montalvo M., MacDonald S., et al. Total parenteral nutrition in the surgical patient: a meta-analysis. Can J Surg. 2001; 44(2): 102–11.
  114. de van der Schueren M., Elia M., Gramlich L., et al. Clinical and economic outcomes of nutrition interventions across the continuum of care. Ann NY Acad Sci. 2014; 1321: 20–40. DOI: 10.1111/nyas.12498
  115. Zhao Q., Li Y., Yu B., et al. Effects of Preoperative Enteral Nutrition on Postoperative Recent Nutritional Status in Patients with Siewert II and III Adenocarcinoma of Esophagogastric Junction after Neoadjuvant Chemoradiotherapy. Nutr Cancer. 2018; 70(6): 895–903. DOI: 10.1080/01635581.2018.1490780
  116. Лейдерман И.Н., Ярошецкий А.И. К вопросу о потребности в белке пациентов отделений реанимации и интенсивной терапии. Вестник интенсивной терапии им. А.И. Салтанова. 2018; 3: 59–66. DOI: 10.21320/1818–474X-2018-3-59-66 [Leyderman I.N., Yaroshetskiy A.I. Discussing protein requirements of intensive care UNIT (ICU) patients. Alexander Saltanov Intensive Care Herald. 2018; 3: 59–66. (In Russ)]
  117. Zhang B., Najarali Z., Ruo L., et al. Effect of Perioperative Nutritional Supplementation on Postoperative Complications-Systematic Review and Meta-Analysis. J Gastrointest Surg. 2019; 23(8): 1682–93. DOI: 10.1007/s11605-019-04173-5
  118. Adiamah A., Skořepa P., Weimann A., et al. The Impact of Preoperative Immune Modulating Nutrition on Outcomes in Patients Undergoing Surgery for Gastrointestinal Cancer: A Systematic Review and Meta-analysis. Ann Surg. 2019; 270(2): 247–56. DOI: 10.1097/SLA.0000000000003256
  119. Migita K., Matsumoto S., Wakatsuki K., et al. Effect of Oral Nutritional Supplementation on the Prognostic Nutritional Index in Gastric Cancer Patients. Nutr Cancer. 2021; 73(11–12): 2420–7. DOI: 10.1080/01635581.2020.1826990
  120. Calder P.C. Immunonutrition. BMJ. 2003; 327(7407): 117–8. DOI: 10.1136/bmj.327.7407.117
  121. Арыкан Н.Г., Шестопалов А.Е., Петрова М.В. Нутритивная реабилитация в онкологии после оперативных вмешательств на верхних отделах желудочно-кишечного тракта. Физическая и реабилитационная медицина, медицинская реабилитация. 2019; 3. DOI: 10.36425/2658-6843-2019-3-3-10 [Arykan N.G., Shestopalov A.E., Petrova M.V. Nutritional rehabilitation in oncology after surgery in the upper gastrointestinal tract. Physical and Rehabilitation Medicine 2019; 3. DOI: 10.36425/2658-6843-2019-3-3-10 (In Russ)]
  122. Huhmann M.B., Cunningham R.S. Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol. 2005; 6(5): 334–43. DOI: 10.1016/S1470-2045(05)70170-4
  123. Fearon K.C., Von Meyenfeldt M.F., Moses A.G., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003; 52(10): 1479–86. DOI: 10.1136/gut.52.10.1479
  124. Гамеева Е.В. Перспективы использования дополнительного перорального питания (сипингов) в нутритивной поддержке онкологических пациентов. Исследования и практика в медицине. 2020; 7(3): 136–45. DOI: 10.17709/2409-2231-2020-7-3-14 [Gameeva E.V. Prospects for the use of additional oral nutrition (siping) in nutritional support of cancer patients. Research and Practical Medicine Journal (Issled. prakt. med.). 2020; 7(3): 136–45. DOI: 10.17709/2409-2231-2020-7-3-14 (In Russ)]
  125. Bozzetti F., Braga M., Gianotti L., et al. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001; 358(9292): 1487–92. DOI: 10.1016/S0140-6736(01)06578-3
  126. Schattner M. Enteral nutritional support of the patient with cancer: route and role. J Clin Gastroenterol. 2003; 36(4): 297–302. DOI: 10.1097/00004836-200304000-00004
  127. Ravasco P., Monteiro-Grillo I., Vidal P.M., et al. Cancer: disease and nutrition are key determinants of patients' quality of life. Support Care Cancer. 2004; 12(4): 246–52. DOI: 10.1007/s00520-003-0568-z
  128. Ravasco P., Monteiro-Grillo I., Camilo M.E. Does nutrition influence quality of life in cancer patients undergoing radiotherapy? Radiother Oncol. 2003; 67(2): 213–20. DOI: 10.1016/s0167-8140(03)00040-9
  129. Ravasco P., Monteiro-Grillo I., Marques Vidal P., Camilo M.E. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck. 2005; 27(8): 659–68. DOI: 10.1002/hed.20221
  130. Ravasco .P, Monteiro-Grillo I., Vidal P.M., et al. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol. 2005; 23(7): 1431–8. DOI: 10.1200/JCO.2005.02.054
  131. Xu R., Chen X.D., Ding Z. Perioperative nutrition management for gastric cancer. Nutrition. 2022; 93: 111492. DOI: 10.1016/j.nut.2021.111492
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2024 Annals of Critical Care

Most read articles by the same author(s)